Mutated coronavirus strain found in Indonesia as cases jump: Report

The capital Jakarta on Sunday saw a record daily increase of more than 1,000 cases, which the city government linked to a higher mobility rate during a mid-August independence celebration.
A more infectious mutation of the new coronavirus has been found in Indonesia, the Jakarta-based Eijkman Institute for Molecular Biology said on Sunday, as the Southeast Asian country's caseload surges.

 
Indonesia reported 2,858 new infections on Sunday, data by the health ministry showed, below the previous day's record 3,308 but above the past month's daily average. Its total number of cases was 172,053, with 7,343 Covid-19 fatalities.

The "infectious but milder" D614G mutation of the virus has been found in genome sequencing data from samples collected by the institute, deputy director Herawati Sudoyo told Reuters, adding that more study is required to determine whether that was behind the recent rise in cases.

The strain, which the World Health Organization said was identified in February and has been circulating in Europe and the Americas, has also been found in neighbouring Singapore and Malaysia.

Syahrizal Syarif, an epidemiologist with the University of Indonesia, warned Indonesians must remain vigilant, as his modelling suggests the country may see its caseload rise to 500,000 by the end of the year.

"The situation is serious .... Local transmission currently is out of control," Syarif said, adding that the number of infections found daily could have been much higher if laboratories were able to process more specimens in a day.

The capital Jakarta on Sunday saw a record daily increase of more than 1,000 cases, which the city government linked to a higher mobility rate during a mid-August independence celebration.

"There needs to be an awareness and a collective effort, be it from the government or the people, in addressing the rising number of cases," Dwi Oktavia, an official at the Jakarta health agency, said in a statement, urging people to stay at home and wear a face mask when they must go out.

Moderna’s patents being probed by US defence dept

Moderna’s patents that were filed or awarded are being probed by the US Department of Defense’s research arm, the Financial Times reported, saying the firm failed to disclose government funding as required by federal law. An advocacy group said researchers didn’t disclose in vaccine patents where they got about $25 million in grants from. Bloomberg


Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel